242 related articles for article (PubMed ID: 8934773)
1. [Clinical study of laryngeal cancer].
Higuchi E; Iizuka K; Shouda H; Takeichi N
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):385-94. PubMed ID: 8934773
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of cervical lymph node metastasis of cN0 laryngeal carcinoma].
Shen CX; Li YS; Wang ZH; Liu C; Lu T; Zeng Q; Wang XQ; Zhu J; Cao YD; Hu GH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 54(5):343-348. PubMed ID: 31137093
[No Abstract] [Full Text] [Related]
3. [Clinical study of subglottic carcinoma].
Kashiwamura M; Fukuda S; Maguchi S; Higuchi E; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1995 Feb; 98(2):254-9. PubMed ID: 7707183
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of 1079 patients with laryngeal cancer].
Fujii T; Sato T; Yoshino K; Inakami K; Nagahara M; Okita J
Nihon Jibiinkoka Gakkai Kaiho; 1997 Aug; 100(8):856-63. PubMed ID: 9293766
[TBL] [Abstract][Full Text] [Related]
5. [A clinical study of 213 patients with laryngeal cancer].
Miyahara H; Yane K; Tsuruta Y; Uemura H
Nihon Jibiinkoka Gakkai Kaiho; 2002 Jul; 105(7):790-8. PubMed ID: 12174612
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on laryngeal cancer].
Ikarashi F; Nonomura N; Nakano Y
Nihon Jibiinkoka Gakkai Kaiho; 1990 May; 93(5):772-8. PubMed ID: 2384832
[TBL] [Abstract][Full Text] [Related]
7. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing tumour relapse after total laryngectomy.
Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of cervical lymphatic metastasis to prognosis of glottic carcinoma: a report of 333 cases].
Zhang Q; Lai FY; Guo ZM; Zeng ZY; Song M; Yu WB; Yang CS
Ai Zheng; 2007 Oct; 26(10):1138-42. PubMed ID: 17927888
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
[TBL] [Abstract][Full Text] [Related]
11. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
12. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
13. T3 glottic carcinoma revisited. Transglottic vs pure glottic carcinoma.
Hao SP; Myers EN; Johnson JT
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):166-70. PubMed ID: 7840924
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].
Yu WB; Zeng ZY; Chen FJ; Peng HW
Ai Zheng; 2006 Jan; 25(1):85-7. PubMed ID: 16405757
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of early laryngeal cancer].
Nagatani G; Mori T; Udaka T; Shiomori T; Ohbuchi T; Suzuki H
Nihon Jibiinkoka Gakkai Kaiho; 2007 Jun; 110(6):447-52. PubMed ID: 17633113
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
[TBL] [Abstract][Full Text] [Related]
17. [Selection of surgical modalities for T3 glottic carcinoma].
Wen SX; Wang BQ; Liu T; Huangfu H; Zhang HL; Zhang CM; Gao W; Feng Y
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):860-3. PubMed ID: 22335954
[TBL] [Abstract][Full Text] [Related]
18. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
Yücetürk AV; Celik O; Eskiizmir G
Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
